The growth of hollow fiber filtration market can be attributed to the rising preference for continuous manufacturing in the biopharmaceutical industry and the increasing demand for biopharmaceuticals.

The hollow fiber filtration market is segmented on the basis of technique, material, application, end user, and region.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=267011039

On the basis of technique, the market is segmented into microfiltration and ultrafiltration. The microfiltration segment is expected to grow at a higher CAGR during the forecast period primarily due to the development and launch of innovative and cost-effective hollow fiber filters, such as single-use hollow fiber filters, in the market.

On the basis of application, the hollow fiber filtration market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. Continuous cell perfusion is expected to be the fastest-growing application segment in the hollow fiber filtration market. This can be attributed to the advantages of hollow fibers in continuous cell perfusion, such as enabling efficient cell separation (with low shear) and allowing robust large-scale manufacturing.

On the basis of end user, the hollow fiber filtration market is segmented into pharmaceutical and biotechnology manufacturers, contract research and manufacturing organizations, R&D departments, and other end users such as research academies and universities. The hollow fiber filtration market for pharmaceutical and biotechnology manufacturers is expected to witness the highest growth during the forecast period majorly due to the increasing demand for biopharmaceuticals and the growing adoption of hollow fiber filtration in pharma and biotech manufacturing facilities (owing to their easy implementation).

The hollow fiber filtration market in the Asia Pacific is expected to grow at the highest CAGR during the forecast period. The high growth in this region can be attributed to the expansion of the biomanufacturing sector in Asia Pacific countries such as China and India, increasing government support, developing R&D infrastructure, and growing outsourcing of bioproduction processes to this region from North America and Europe.

Factors such as the rising income levels and the presence of advanced medical infrastructure have led to the growth of the pharmaceutical and biotechnology industries in countries such as India and China. This growth in the target industries in these emerging countries is expected to create potential growth opportunities for market players in the coming years.